IRT 2018 convenes nearly 200 clinical and supply chain pioneers each year and has established itself as the largest, most renowned event of its kind, dedicated to solution-oriented discussions, practical case studies and peer-to-peer benchmarking
Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job, your attendance will accelerate your growth and your organization's performance in the heathcare ecosystem.
Let’s Build A Bridge!
Join the Bridging Clinical Research & Clinical Health Care Collaborative, April 4-5 in National Harbor, MD – The only forum where clinical research and health care professionals come together to envision a collaborative...
DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit,...
The 9th Annual Summit for Clinical Ops Executives (SCOPE Summit), taking place February 12-15, 2018 in Orlando, FL, will offer three stimulating days of in-depth discussions in 18 different conferences. www.SCOPEsummit.com
Join 150+ senior-level clinical quality, compliance and operations professionals from pharma, biotech and device companies, to discuss strategies for ensuring clinical trial integrity by optimizing and managing the quality of vendors and sites.
Drug counterfeiting: a pharmaceutical industry problemCounterfeiters rely on two things: poorly secured pharmaceutical supply chains; and the fact people want to pay less for less for drugs.Most fake erectile dysfunction drugs seized in Europe contain...
This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...
It is a well-established principal that even the most promising API, monoclonal antibody or therapeutic peptide can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream and is bioavailable.But,...
How healthy is demand for bioavailability enhancement services? Is the growth of the generics sector driving the market or do innovative pharma firms determine the type of solubility solutions that are available.When biopharmaceutical are injected they...
Tablets have been around for almost 200 years. In this presentation we trace the history of their development, from the accidental invention of the sustained release pill through to the latest breakthroughs in bioavailability enhancement, this talk will...
How do you take a successful bioavailability solution from the laboratory to the pilot plant and on to commercial-scale production? What are the potential pitfalls and considerations involved in successfully scaling-up the production of a poorly soluble...
Creating an Amorphous Solid Dispersion (ASD) is an increasingly popular way of improving Active Pharmaceutical Ingredient (API) solubility. But while the approach can be successful, the big problem is demonstrating ASD stability, preventing ingredients...
This webinar will give you a better understanding of how the end of one-size-fits all medicine, and current oncology drug developments in diagnosis and biomarkers positively impact clinical trials. It will also address key oncology drug development barriers...
Clinical trials in the Asia Pacific are increasing exponentially. Numerous sponsors and CROs have accessed this region in recent years to take advantage of high performing, cost effective sites. To many sponsors though, Asia Pacific appears an impenetrable...
